HomeApproved Treatments

Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

Santhera Announces Approval in Hong Kong for AGAMREE (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Approved Treatments

Hong Kong DoH Approves AGAMREE® for Duchenne Muscular Dystrophy Treatment.

Santhera Pharmaceuticals announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged 4 years and older.

Read More

- Follow Us -
DMDWarrioR Instagram
Previous article
Researchers Discover 18-Digit Code (Wnt7a) that Allows Proteins to Hitch a Ride Around the Body
Next article
UK Approves Givinostat (Duvyzat) for Duchenne Muscular Dystrophy Treatment

LEAVE A REPLY

Please enter your comment!
Please enter your name here


Hot Topics

Load more

Related Articles

Load more

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

Shanghai Jiao Tong University School of Medicine Begins Clinical Trials of LE051 Exon 51 Skipping Therapy

Research 0
The purpose of LE051 study is to evaluate the...

Translarna (Ataluren) Rejected by EMA: Marketing Authorization Not Renewed

Press Releases 0
In May 2024, PTC Therapeutics had been announced that...

DMD WarrioR’s Turkish Representative Shares His Views on Elevidys Gene Therapy: Is It Effective and Why Is It Expensive?

Editorials 0
The efficacy of Elevidys in treating Duchenne muscular dystrophy...

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Treatments 5
A genetic condition known as Duchenne muscular dystrophy (DMD)...

What is Duvyzat (Givinostat)?

Approved Treatments 1
For individuals with Duchenne muscular dystrophy (DMD), adults and...

Cures of Duchenne (List of All Researches)

Research 14
Dystrophin Gene Therapy MechanismCompanyDrugStatus Micro-dystrophin Gene Replacement Sarepta TherapeuticsElevidys/SRP-9001ApprovedMicro-dystrophin Gene ReplacementPfizerPF-06939926DiscontinuedMicro-dystrophin Gene...

© 2024 - 2025 DMD Warrior. All rights reserved.